冬野 雄太

Medicine & Life Sciences

1. Crohn Disease 100%
2. Ulcerative Colitis 49%
3. Inflammatory Bowel Diseases 35%
4. Hemorrhage 34%
5. Genome-Wide Association Study 32%
6. Microbiota 31%
7. Colonoscopy 27%
8. Indigo Carmine 27%
9. Capsule Endoscopy 27%
10. Genes 27%
11. Diverticular Diseases 26%
12. Multicenter Studies 24%
13. Population 23%
14. Gastrointestinal Hemorrhage 22%
15. Infliximab 20%
16. Cohort Studies 19%
17. Primary Hypertrophic Osteoarthropathy 18%
18. Helicobacter pylori 18%
19. Prostaglandins 16%
20. Balloon Enteroscopy 15%
21. Single-Balloon Enteroscopy 15%
22. Christianity 15%
23. Retrospective Studies 14%
24. Ulcer 14%
25. Stomach 14%
26. Disease Susceptibility 14%
27. Single Nucleotide Polymorphism 14%
28. Low-Volume Hospitals 13%
29. Marginal Zone B-Cell Lymphoma 13%
30. Odds Ratio 13%
31. Ustekinumab 13%
32. High-Volume Hospitals 13%
33. Dysbiosis 12%
34. Barium Enema 11%
35. Quantitative Trait Loci 11%
36. Diverticulum 11%
37. Endoscopy 11%
38. Follicular Lymphoma 11%
39. Therapeutics 10%
40. Biliary Liver Cirrhosis 10%
41. Gastrointestinal Microbiome 10%
42. Gastric Mucosa 10%
43. Mutation 10%
44. Ileum 9%
45. Small Intestine 9%
46. HLA Antigens 9%
47. Blood Vessels 8%
48. Enteritis 8%
49. Ligation 7%
50. Stomach Neoplasms 7%